Pre-Application Webinar and Frequently Asked Questions (FAQ) for RFA-CA-18-018 Prevention of HPV-related Cancers in HIV-infected individuals: United States-Latin American-Caribbean Clinical Trials Network: Partnership Centers (U54)

Notice Number: NOT-CA-18-113

Key Dates
Release Date: September 26, 2018

Date for Pre-Application webinar for RFA-CA-18-018:
Friday, October 12, 2018 at 1:00 p.m.- 2:00 p.m. (EDT)

Related Announcements
RFA-CA-18-018

Issued by
National Cancer Institute (NCI)

Purpose

On August 28, 2018, NCI issued the Funding Opportunity Announcement (FOA) RFA-CA-18-018 entitled "Prevention of HPV-related Cancers in HIV-infected individuals: United States-Latin American-Caribbean Clinical Trials Network: Partnership Centers (U54 Clinical Trial Required)".

To assist potential applicants to the above-referenced FOA, this Notice provides information regarding an upcoming Pre-Application Webinar to be held on Friday, October 12, 2018 at 1:00 p.m.- 2:00 p.m. (EDT) and the availability of a Frequently Asked Questions (FAQ) document.

Pre-Application Webinar
A public pre-application webinar will be held Friday, October 12, 2018 at 1:00 p.m.- 2:00 p.m. (EDT) to provide information about the FOA to prospective applicants. NCI staff will provide an overview of the FOA and the application review process and answer questions from prospective applicants. The webinar is open to all prospective applicants. Participation in this webinar, although encouraged, is optional and is not required for the submission of an application in response to RFA-CA-18-018.
Information about how to participate in the webinar will be posted here:
https://prevention.cancer.gov/ulacnet. Registration is required to participate. Potential applicants are encouraged to submit their questions to sahasrabuddhevv@mail.nih.gov in advance of the teleconference. Webinar Slides will be available at https://prevention.cancer.gov/ulacnet two days following the completion of this webinar.

Frequently Asked Questions (FAQ)
A Frequently Asked Questions (FAQ) document to address common questions from potential applicants regarding RFA-CA-18-018 is available at: https://prevention.cancer.gov/ulacnet. All applicants are encouraged to review the FAQ document prior to submitting their application. We anticipate updating the FAQ document as needed and recommend that applicants check back for updates to the FAQs regularly until their submission date.

Inquiries

Please direct all inquiries to:

Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
National Cancer Institute (NCI)
Telephone: 240-276-7332 
Email: sahasrabuddhevv@mail.nih.gov